The following factors significantly influenced OS in bivariate analysis (Table 2b): poor baseline WHO performance status ≥2, baseline high neutrocyte count, baseline low albumin level, low baseline hemoglobin level, the maximal diameter of the largest tumor >10 cm (Fig. 2b), and the lack of resection of residual disease during imatinib therapy (Fig. 2c). Here, ALB is linked to neoplasm.